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The Karonga Health and Demographic Surveillance System (Karonga
HDSS) in northern Malawi currently has a population of more than
35 000 individuals under continuous demographic surveillance since
completion of a baseline census (2002–2004). The surveillance system
collects data on vital events and migration for individuals and for
households. It also provides data on cause-specific mortality obtained
by verbal autopsy for all age groups, and estimates rates of disease for
specific presentations via linkage to clinical facility data. The Karonga
HDSS provides a structure for surveys of socio-economic status, HIV
sero-prevalence and incidence, sexual behaviour, fertility intentions
and a sampling frame for other studies, as well as evaluating the
impact of interventions, such as antiretroviral therapy and vaccination
programmes. Uniquely, it relies on a network of village informants to
report vital events and household moves, and furthermore is linked to
an archive of biological samples and data from population surveys and
other studies dating back three decades.
Keywords Demography, epidemiology, census, sub-Saharan Africa, Malawi,
HIV, population dynamics, vital statistics, mortality, cause of
death, life expectancy
Origins of the Karonga HDSS
The Karonga Prevention Study (KPS), established in
the Karonga District of rural northern Malawi, has
focused on epidemiological, clinical and immunolo-
gical studies of infectious diseases of public health
importance. The KPS was designed in 1979, initially
as a large cohort study of risk factors for leprosy,
covering the entire district of Karonga. In the
1980s,1 two total population surveys were conducted
to identify and examine individuals and to collect
socio-economic and other household level data. In
1986, the programme assumed responsibility for dis-
trict-wide tuberculosis diagnosis and treatment, and
in the same year, KPS became the largest vaccine trial
in Africa, with our investigation of the effects of
Bacillus Calmette-Gue´rin and/or killed M.leprae against
both leprosy and tuberculosis (TB).2 TB epidemiolo-
gical studies continue district wide today.3 In 1987,
studies were conducted that established the presence
of HIV, which has since then become a major theme
of our research.
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The Karonga HDSS was initiated in 2002 principally
to provide a platform for epidemiological studies of
HIV and HIV-associated infectious disease and to
monitor the impact of interventions. The location of
the Karonga HDSS was determined largely by the
availability of HIV prevalence and incidence data that
identified the first cases in the area in 1982 through
retrospective testing of archived material.4 The
Karonga HDSS became a member of the INDEPTH
international network of field sites with continuous
demographic evaluation of populations and their
health in developing countries (http://www.indepth-
network.org) in 2004, and was one of the founder
sites of the ALPHA network for analysis of longitu-
dinal, population-based HIV/AIDS data in Africa
(http://www.lshtm.ac.uk/eph/psd/alpha) in 2005.
What does the Karonga HDSS
cover now?
The core Karonga HDSS generates data on basic
demographic indices, as well as cause-specific mortal-
ity for all age groups; population level data have also
been routinely collected on vaccine coverage and
socio-economic status. Active case finding for TB
(via cough inquiry) has also been conducted.
The current programme, which commenced in 2006,
combines detailed clinical and behavioural studies
in individuals, with population-based epidemiolo-
gical and demographic studies to: (i) monitor changes
in HIV incidence and transmission of drug resist-
ant virus; (ii) assess changes in sexual behaviour
and attitudes through both quantitative and qualita-
tive studies; (iii) measure HIV-attributable mortality
and morbidity; (iv) identify factors affecting anti-
retroviral treatment (ART) adherence; (v) evaluate
socio-economic and demographic impact of HIV and
provide estimates of future trends in the HIV epidemic
(to identify target areas for future interventions);
(vi) evaluate the success of the programme for pre-
vention of mother-to-child transmission of HIV; (vii)
understand the impact of new vaccine introduction on
child mortality and, more recently, (viii) explore in
detail contact patterns and the transmission dynamics
of M.tuberculosis. To this end, multiple population level
surveys have generated comprehensive data on sexual
behaviour, fertility intentions, HIV and herpes simplex
virus-2 sero-prevalence and incidence, detailed educa-
tional attainment and socio-economic status, anthro-
pometry in children and mothers and tuberculin skin
tests in children aged under 5 years. Furthermore,
these data are linked to health facility data from
ART, antenatal and paediatric clinics.
Research plans for the near future include an expan-
sion into the area of non-communicable diseases, par-
ticularly diabetes and hypertension (which account in
part for an increasingly high burden of disease in this
setting), an increased emphasis on intervention studies
and establishment of an urban partner site in Lilongwe.
Where is the Karonga HDSS area?
The Karonga HDSS surrounds the port village of
Chilumba, on Lake Malawi, in the southern part of
Karonga District (Figure 1a), where the project head-
quarters are found. The surveillance area is located be-
tween latitudes 10.388 and 10.508S and longitudes
34.088 and 34.278E, covering an area of approximately
135 km2. The lake shore and the Nyika National
Park form the boundaries to the east and west, respect-
ively, whereas the boundaries to the north and south
are delineated by village boundaries—and here three
(of four) health facilities that serve the area are found
(Figure 1b). The climate is hot and dry from September
to December, with rains from January to May, and
cool and dry from June to August. The Karonga HDSS
population is predominantly rural, and the economy is
based upon subsistence agriculture, fishing and petty
trading. In the rural area, the households are scattered,
although a higher density of households exist in two
semi-urban settlements—a trading centre (Uliwa) on
the main road from Tanzania into Malawi, and
Chilumba itself (Figure 1b). Approximately 15% of the
Karonga HDSS population live in these semi-urban
areas, and 50% live within one kilometre of a tarmac
road.
Before the initial enumeration, meetings were held
with the Wasambo (the traditional authority with re-
sponsibility for the area), and additional sensitisation
sessions were held with the group village headmen
(each representing several villages). During the base-
line census, further meetings were held with each vil-
lage headman and the ndunas (village elders) before
entering each new location to gain consent for estab-
lishing a camp and to conduct the survey. At this
time, ndunas and other responsible community indi-
viduals were recruited as key informants to report
vital events and household migrations.
Photograph 1 Karonga HDSS—survey team recruiting
family for survey (written consent obtained from partici-
pants). Photograph: Vijay Bansode
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Handheld global positioning system devices were
used to map the surveillance area and to mark village
boundaries, major and minor roads and tracks, rivers,
key institutions (such as health facilities and schools)
and individual household locations. Each village was
further divided into smaller geographical areas
(known as clusters) that represent 20–30 households.
Groups of approximately 10 clusters in a defined geo-
graphical area were combined to form the 21 report-
ing groups, which make up the surveillance area
(Figure 1c). The geographical data are stored in
ARC-info.
Who is covered by the Karonga
HDSS and how often have they
been followed up?
At the end of 2011, 35 730 individuals from 8285
households were under observation in the Karonga
Figure 1 (A) Location of Karonga district and Karonga HDSS in Malawi; (B) map of Karonga HDSS showing household
distribution, primary and secondary roads and location of health facilities; (C) map of Karonga HDSS showing cluster and
reporting group boundaries. Data and boundaries from Karonga HDSS databases at end 2011
Photograph 2 Karonga HDSS—nurse recruiting mother
and child for paediatric disease surveillance in health facility
(written consent obtained from participants). Photograph:
Anna Molesworth
678 INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
D
ow
nloaded from
 https://academ
ic.oup.com
/ije/article-abstract/41/3/676/837690 by U
niversity of G
lasgow
 user on 15 February 2019
HDSS. Members of each household within the geo-
graphical boundaries are invited to participate (and
visitors were also captured in the baseline survey).
In practice, refusal is on a household rather than an
individual basis, and less than 1% of households
(usually those of spiritualists or other objecting reli-
gions) do not participate. For the purpose of the
Karonga HDSS, a household is defined as a group of
individuals who usually live together and recognize
the same household head, although two or more
households may share a household head, as fre-
quently occurs within polygynous unions. A member
of a household is a person who is accepted as belong-
ing to the household and may include schoolchildren
who temporarily live somewhere else during term-
time. A visitor is defined as someone who is expected
to return to their home elsewhere, irrespective of their
duration in the current household. The definitions of
household, member and visitor are based on cultural
perceptions.
During the initial baseline census in each cluster, a
key informant resident in that cluster was selected
and trained to keep a real-time record of vital
events and whole household movements within his
or her group of households, by making notes pencilled
in a printed household register generated from the
baseline census data. A nominated KPS interviewer
(supervisor) meets with the key informants represent-
ing each reporting group (of 10 or so clusters) at a
designated location each month (monthly update) to
update the supervisor’s household register for each
cluster with the vital event reports. At this meeting,
refreshments are provided, and the key informant is
given a nominal sum (currently about $3) to compen-
sate them for their time. When births are reported,
the supervisor will visit the household immediately
after the meeting to register the birth and administer
a brief questionnaire; however, in the event of a
death, a medical assistant will visit the household to
register the death and to conduct a verbal autopsy
after an appropriate mourning period (usually 2–3
weeks). If the birth, or death, is in a new household
or if the death has resulted in household dissolution
or out-migration, members of in-migrating house-
holds are registered, or departure information is
sought on dissolved/departed households.
Every year, an annual update session is held with
the key informants, at which they report whole
household migrations during the previous 12
months, (and the vital events of the previous month
are also reported). Migrations are reported annually to
ensure that true demographic change is not obscured
by the recording of temporary, frequently reversed,
inter-household moves. The annual update meeting
with key informants is followed by an annual
re-census, which further identifies individual out- or
in-migrations and gives an opportunity to conduct
socio-economic interviews. At the next monthly
update session, the supervisor and key informant
are issued with revised household registers for each
cluster that reflect updated information on migrations
and vital events, and feedback is given on births and
deaths in their village. From time to time, a key in-
formant retires and a new one is trained.
Paper questionnaires are returned to the KPS data
office, where, after registration, identity numbers are
issued to new births, and migrants are investigated to
see whether they have had previous contact with the
programme, before issue or re-issue of identity num-
bers. Since its inception, the programme has used a
rigorous identification process that facilitates reliable
re-identification of individuals even if they have not
been under observation for many years. Each individ-
ual has a static and unique identity number, as well
as a unique Continuous Registration System (CRS)
number [formed by concatenating the reporting
group number, cluster number, household number
and member number (place in that household when
first identified)]. If individuals (or households) move
within the Karonga HDSS, new CRS numbers will be
assigned, but the identity number remains
unchanged.
Of the 35 730 individuals under observation, at the
end of 2011, 48% (16 818/35 730) were male, 18%
(6265/35 730) were under 5 years and 48% (17 158/
35 730) were under 15 years of age. In all, 47%
(16 684/35 730) of the population were aged between
15 and 59 years, and 5% (1888/35 730) were aged 60
years and above.
An active community engagement programme is in
place, which includes Key Informant Days, where
groups of key informants visit the project headquar-
ters for presentations on recent findings to feed back
to the community. They visit the laboratories and
data office to see how specimens and data are
held, and participate in quizzes and dramas to facili-
tate understanding of the research process.
Community sensitisation events (usually one per re-
porting group, with typical attendances of 200–800
people) are held at the time of introduction of new
studies, with dancing, dramas and question and
answer sessions.
What is measured and how have
the Karonga HDSS databases been
constructed?
The core data collected throughout the Karonga
HDSS include individual and household identifying
information, parent identification and spousal rela-
tionships at each time point. Sufficient data are
collected to link individuals of all ages to both par-
ents, facilitating genetic and orphan-hood studies.
Basic socio-economic data are also collected as part
of core Karonga HDSS activity. Verbal autopsies col-
lect detailed data on symptoms and signs during the
terminal illness, allowing assignment of cause of
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death following physician review or computer algo-
rithm. Core data items are summarized in Table 1.
Other data are collected in the context of Karonga-
wide surveys, population samples or during health
facility attendances.
The detailed identifying information at first or re-
newed contact with the Karonga HDSS team enables
linkage through the identity number system to all
other data (more than 1 million individual contacts)
and biological samples (more than 2 00 000) held by
the programme.
Karonga HDSS data are double entered into MS
Access 2007 databases as soon as any identification
and coding procedures are complete, and discrepan-
cies between the two databases are corrected weekly.
The data are held in multiple event tables in the data-
bases with a single view table describing all Karonga
HDSS events. Daily data are extracted by a pro-
grammed script to integrate new data to the
Karonga HDSS analysis database, to update the gen-
eric programme database holding records of every
contact with an individual and to run consistency
checks. The MS access data are held on a Linux
server and backed up twice daily to external media.
Key findings and publications
We established early on that our system of inform-
ants was reliable in capturing both births (97%) and
deaths (99%),5 and the Karonga HDSS contributes
these validated demographic data to INDEPTH mono-
graphs, which are routinely published (http://www
.indepth-network.org/index.php?option¼com_content
&task¼view&id¼76&Itemid¼164). Basic demographic
indices for the period 2005–2010 are summarized in
Table 2, and population pyramids from 2004 and 2010
are shown in Figures 2a and 2b. The pyramids reflect
the significant mortality in young children, the mor-
tality in young adults as a consequence of the HIV
epidemic and the out-migration of teenagers and
young adults of both sexes from this rural area to
seek education and employment. The table shows dra-
matic sustained reductions in mortality in all age
groups, except for neonates. Population growth is
approximately 2.5% per annum, but this is largely
driven, not by birth and death rates, but by the
much higher in- and out-migration rates, with the
latter predominating.
Our most important findings to date relate to the
impact of ART on the population. We showed the
first evidence of a population-level decline in adult
mortality (16% drop) because of the rapid scale-up
of ART, free at the point of delivery, even though by
that stage, only an estimated one-third of those in
need had accessed ART.6 At that time, the improve-
ments were confined to those near the roadside with
easier access to the services provided in the district
town. Subsequently, as a clinic opened within the
Karonga HDSS area, a further decline in all-cause
mortality (32% reduction) was observed. This ex-
tended to more remote areas,7 and estimated treat-
ment coverage was 70%.
Combining our data, with those from other
INDEPTH/ALPHA demographic sites, with HIV data,
we have confirmed the importance of local provision
of ART for mortality improvement,8 validated projec-
tions of ART need from the age and sex profile of
HIV-infected people9 and compared knowledge of
HIV status and uptake of ART between demographic
sites.10
Using the Karonga HDSS for structured sampling,
we identified that early in the ART programme,
screening for eligibility based on clinical staging
alone would miss two-thirds of those eligible by com-
bined clinical and CD4 staging.11 We investigated the
gender differences in ART uptake combining quanti-
tative and qualitative approaches, and found that the
nurturing role of women was key to their early pres-
entation, whereas men’s wider need for social accept-
ance resulted in delays.12
An analysis of cause-specific mortality has shown
that, following the roll-out and decentralisation of
ART, HIV/AIDS is no longer the leading cause of
adult death in this area, and non-communicable
causes such as cardiovascular disease predominate.13
Examining HIV incidence in discordant couples in a
population-based programmatic setting study, shows
that transmission is prevented by ART, whereas trans-
mission from those who are untreated continues, with
husband-to-wife transmission higher than wife-to-
husband.14 Drug resistance mutations were found in
20% of drug-naive individuals in the Karonga HDSS
area, although the clinical significance of these is
uncertain.15
Childhood mortality studies have shown that HIV
closed the survival gap between the children of the
very poor and the rest of the population, as HIV in the
early part of the epidemic was associated with greater
wealth.16 Mortality rates in all child-age groups
declined despite HIV17 even before ART was likely to
have had an impact. One-fifth of all deaths in chil-
dren aged under 15 years were attributable to HIV in
this pre-ART period.17
Methodological studies nested within the Karonga
HDSS demonstrated that although home-based rapid
HIV testing is highly sensitive and specific,18 testing
in surveys when a high proportion of individuals al-
ready know their status should be interpreted with
caution, as underestimates arise because of selective
test refusals.19 Methods to correct the bias have been
explored.
In our sexual behaviour surveys, we triangulated re-
ports of extra-marital partnerships to show that
under-reporting by women was strongly age depen-
dent, but that young men also under-reported in
this setting.20 We also found that girls with early me-
narche start sex and marry early, leading to school
drop-out, and that girls with late menarche had the
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Table 1 Information collected or checked at routine events
Main data item Additional information
Household data
Name of head of household
Village name
Date since household was in current location
Latitude, longitude
At in-migration to HDSS or birth registration
Names current and previous
Sex
Date of birth estimates as required
Date of in-migration (in migrants only)
Name/identifier of mother vital status of mother and household/village
Name/identifier of father vital status of father and household/village
Previous contact with KPS where last seen
Siblings alive in Karonga shared parent(s)
Current household when joined household
Position in household
Was person seen or proxy informant used informant name and relationship
Reason for immigration (in-migrants only)
Previous household and village (in-migrants only)
At recensus—additional information (as of 2011, changes over time)
Relationship to household head
Parental educational achievement
Marital status number of current spouses or co-spouses
Spouse identification details dates of marriage
Educational achievement
Main occupation
Reason for leaving school age at leaving school
Details of school absences (if currently enrolled in school)
Vaccination history (if less than 5 years old)
Bacillus Calmette-Gue´rin, Polio, Pentavalent, Measles
Pneumococcal conjugate vaccine
Mobile phone access do they have exclusive use
Participation in mass campaigns e.g. measles vaccine campaign, filariasis mass drug treatment
TB case finding, cough, haemoptysis sputum collection
At death registration (accompanied by age-specific verbal autopsy form)
Informant informant name and relationship
Association with deceased during terminal illness
Pregnancy details (if neonatal death)
Health document review
Vaccination history (if less than 5 years old)
Date of death/stillbirth
Category of place of death name of health facility if required
Category of care sought during terminal illness
At out-migration
Date of migration
Destination
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same educational achievement as boys.21 Using our
detailed sexual behaviour data, we have also explored
the interpretation of the UNAIDS recommended
methods of measuring concurrency in sexual relation-
ships, thought to be key to understanding the dy-
namics of HIV transmission.22
We used our population-survey anthropometry data
to investigate the effects of the new WHO Growth
Standards on the measures of prevalence of stunting,
underweight and wasting, compared with the previ-
ously used National Centre for Health Statistics refer-
ence, finding that the new standards gave higher
estimates for all indices, especially in early infancy.23
There was no difference in their ability to identify risk
factors for malnutrition.
Vaccination coverage in children was high eventu-
ally, but frequently delayed, particularly in those from
poorer families and living at a distance from health
facilities.24
For full KPS publications, visit http://www.lshtm.ac.
uk/eph/ide/research/kps/publications/index.html, and
ALPHA network articles are summarized at http://
www.lshtm.ac.uk/eph/psd/alpha/publications/index
.html.
Future analysis plans
Analyses are ongoing in many areas; we continue to
evaluate the impact of HIV and ART on mortality,
morbidity and socio-economic status. We are also
undertaking a detailed analysis of child mortality
trends and causes of death.
In a combined INDEPTH and ALPHA networks ini-
tiative, we are using our detailed verbal autopsy ques-
tionnaire data to validate Inter-VA (http://www
.interva.net)—a computer model that facilitates inter-
pretation of verbal autopsies and their application to
populations by assigning probabilities of multiple
causes to each death.
Another stream of work analyses data on fertility in-
tentions and the impact of unplanned pregnancies on
existing child welfare, the consistency of partners’ fer-
tility desires within marital unions and the effect on
fertility desire of knowledge of HIV. Uptake of modern
methods of contraception and the relationship to ex-
pressed fertility intentions in HIV-positive, -negative
and -discordant couples and the fertility of women al-
ready on ART are also being explored, as are fertility
patterns and influences in both men and women.
We are exploring further the dynamics of educa-
tional achievement and sexual behaviour, and other
influences on female retention in school.
A study of carriage of pneumococcus in a population
birth cohort, both HIV exposed and unexposed, pre-
and post-introduction of pneumococcal conjugate vac-
cine is currently being analysed and linked to the
rates of morbidity from childhood pneumonias and
other febrile illnesses in the Karonga HDSS area.
What are the main strengths and
weaknesses?
A major scientific strength of the Karonga HDSS is
the nesting of the demographic survey in the historic
cohort dating from 1979 and the full linkage to
longitudinal data (demographic, epidemiological,
clinical) and biological samples, through our well-
established identification procedures. These proced-
ures also allow us to track individuals between
households and areas and to identify formerly
Table 2 Demographic characteristics of the Karonga HDSS
2005 2006 2007 2008 2009 2010
Total population 31,325 32,569 33,357 33,518 33,655 34,747
Crude birth rate per 1000 PY 46.6 43.8 43.1 39.8 40.2 37.3
In-migration rate per 1000 PY 93.9 81.9 68.3 72.0 78.1 73.2
Out-migration rate per 1000 PY 81.0 80.9 92.4 98.0 99.7 76.7
Crude death rate per 1000 PY 10.9 10.0 8.7 8.1 7.1 6.1
Adult mortality rate per 1000 PY 12.5 11.7 10.1 10.0 8.4 6.9
Life expectancy at birth (years) 57.7 59.0 62.0 62.9 66.8 69.4
Neonatal mortality rate per 1000 live births 24.7 20.4 23.1 20.3 24.5 15.5a
Post-neonatal mortality rate per 1000 live births 30.2 28.1 18.9 21.8 17.8 19.4
Infant mortality rate per 1000 live births 54.9 48.6 42.0 42.1 42.3 35.0
Under-five mortality rate per 1000 live births 85.8 80.2 75.0 66.9 61.6 59.1
Basic vital statistics based on population estimates, 2005–2010.
aThis figure is correct; however, trend should not be over-interpreted as based on only 20–30 neonatal deaths per year.
PY¼ per year
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resident in-migrants even after decades of absence.
Our presence throughout the district also allows tra-
cing of individuals anywhere within Karonga (popu-
lation: 250 000 individuals), if follow-up of specific
individuals is required. Full parental linkage (both
in and out of marriage) allows us to study genetic
linkages, orphan-hood and male fertility patterns.
The methodological advantages of our system in-
clude the real-time reporting from village informants.
This brings benefits not only from contemporaneous
reporting (particularly important for birth registration
in the presence of neonatal and infant mortality, and
accurate verbal autopsies) but also enables the
Karonga HDSS team to have a relatively low profile
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mid-point of these years
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in the community. Other than the annual census or
special surveys, a household is only visited if a vital
event occurs.
Our active community engagement programme and
long-standing involvement with disease control pro-
grammes (notably leprosy, tuberculosis and HIV)
result in good relations with the community and gen-
erally high consent rates in all studies.
A potential limitation scientifically is that this is a
heavily studied area with a consequent risk of study
fatigue (although our experience is that this does not
have major impact) or behaviour modification that
may bias observational studies. In terms of the meth-
ods, as reporting of individual (rather than house-
hold) migrations by key informants has proved too
difficult to implement, in-migrants who come and
leave between two re-census periods may be missed
from registration. Using key informants to report vital
events by proxy means we cannot capture some sen-
sitive events, such as pregnancies.
Data sharing and collaboration
Currently our data are held on site and are not avail-
able remotely. Applications to access HDSS data for
collaborative analysis are encouraged and can be
made by proposal submission to the Deputy
Director/ Scientific Programme Manager: mia.cram-
pin@lshtm.ac.uk (http://www.lshtm.ac.uk/eph/ide/re-
search/kps/index.html). Subject to funding, in the
next few years, selected Karonga HDSS data will be
made available online via an open access site (e.g. via
the INDEPTH platform), and procedures for applying
for use and generating appropriate additional data
sets will be streamlined.
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KEY MESSAGES
 Karonga HDSS is a health and demographic surveillance system of 35 000 individuals based on a
validated and cost-effective community reporting structure.
 Karonga HDSS was designed as a platform for epidemiological and clinical studies using
well-established identification procedures enabling linkage to health and socio-economic data and
archived biological specimens. Our capacity to re-identify individuals and to link children with both
parents facilitates longitudinal investigations of individuals and families, spanning decades, including
genetic relationships.
 Current research areas include HIV, TB and other infectious diseases, and behavioural studies related
to transmission, although in response to changing health priorities in Malawi, future plans include
diversification to non-communicable diseases (e.g. hypertension and diabetes).
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